Clinical Evidence: Red Light Therapy for Wound Healing - What the Research Shows

Red light therapy (also called photobiomodulation or low-level laser/light therapy) has been studied for wound healing across laboratory, animal, and clinical settings for several decades. This article reviews three key pieces of research and explains what the findings mean in plain terms - including being upfront about which studies are primary clinical trials and which are reviews of existing literature.

---

Study 1: Whelan and colleagues (2001) - NASA-Funded Primary Research

Citation: Whelan HT, Smits RL Jr, Buchman EV, Whelan NT, Turner SG, Margolis DA, Cevenini V, Stinson H, Ignatius R, Martin T, Cwiklinski J, Philippi AF, Graf WR, Hodgson B, Gould L, Kane M, Chen G, Caviness J. Effect of NASA light-emitting diode irradiation on wound healing. Journal of Clinical Laser Medicine and Surgery. 2001;

Study type: Mixed pre-clinical and clinical. Includes in vitro (cell culture) work, animal model experiments, and human case data.

Wavelengths studied: 670nm, 720nm, and 880nm LED array

What the Research Found

This NASA-funded study is one of the most frequently referenced pieces of primary research on LED photobiomodulation for wound healing. The findings span three levels of evidence:

In vitro (cell culture) results:

• Mouse fibroblast growth increased 140-200% compared to non-irradiated controls
• Rat osteoblast (bone cell) growth increased in the same range
• Rat skeletal muscle cell growth also increased 140-200%
• Human epithelial cell growth increased 155-171%

Animal model results:

• In ischemic rat wound models (where blood flow is restricted, mimicking difficult-to-heal wounds), wound size decreased by up to 36% when LED irradiation was combined with hyperbaric oxygen treatment

Human case data:

• Over 40% improvement in musculoskeletal training injuries was reported in US Navy SEAL members who used the LED devices
• 47% reduction in pain was reported in paediatric patients with oral mucositis (mouth sores caused by chemotherapy)

Important context: The in vitro figures (140-200% cell growth) are from laboratory cell cultures, not from people applying a device to skin. Cell culture results do not always translate directly to the same magnitude of effect in the human body. The human data in this study is described as case data, not a controlled clinical trial. That said, this remains a foundational and peer-reviewed piece of research in the photobiomodulation field.

---

Study 2: Chaves and colleagues (2014) - Review of LED vs Laser in Wound Healing

Citation: Chaves MEA, Araujo AR, Piancastelli ACC, Pinotti M. Effects of low-power light therapy on wound healing: LASER x LED. Anais Brasileiros de Dermatologia. 2014;

Study type: Systematic review of 68 in vitro and animal studies. This is NOT a clinical trial. It analysed and summarised existing pre-clinical research rather than recruiting human participants.

Wavelengths covered: Various, across the therapeutic window used in pre-clinical research

What the Review Found

The primary question this review addressed was whether LED devices and laser devices produce comparable biological effects, since much of the foundational photobiomodulation research used laser sources. Key findings from the 68 studies reviewed:

• Decreased inflammatory cell presence in wound tissue
• Enhanced fibroblast proliferation (the cells responsible for tissue repair and collagen production)
• Stimulated angiogenesis (formation of new blood vessels to supply healing tissue)
• Granulation tissue formation (the connective tissue that fills a wound during early healing)
• Increased collagen synthesis

The review concluded that LED and LASER promote similar biological effects. This matters because it supports the use of LED devices (like home-use panels and masks) as valid delivery mechanisms for photobiomodulation, not just clinical laser equipment.

Limitation to note: Because this is a review of pre-clinical (lab and animal) studies, the biological mechanisms and effects described have not all been directly validated in large-scale human trials at this point. Reviews of this type are valuable for understanding mechanisms and patterns across studies, but are a step removed from direct clinical evidence in humans.

---

Study 3: Avci and colleagues (2013) - Narrative Review of Low-Level Laser/Light Therapy

Citation: Avci P, Gupta A, Sadasivam M, Vecchio D, Pam Z, Pam N, Hamblin MR. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Seminars in Cutaneous Medicine and Surgery. 2013;

Study type: Narrative review. This is NOT a clinical trial. It summarises and discusses findings from multiple published studies across skin applications of photobiomodulation.

Wavelengths referenced: 630nm, 633nm, 660nm, and 830nm across the cited studies

What the Review Found

Burns healing data referenced: The review cites data from 9 patients with second-degree burns where daily LED therapy was associated with wound healing occurring approximately 50% faster than controls. This is a small dataset and described within the context of a broader review, not as a standalone controlled trial.

Photoaging data referenced: The review also references a multicenter trial in which over 90% of participants showed improvement of at least one Fitzpatrick photoaging category following photobiomodulation treatment. This suggests potential benefits for skin quality beyond wound healing specifically. For facial skin concerns, the Lumovex Spectrum Pro Mask delivers both 660nm and 850nm wavelengths - the same ranges cited throughout the review - directly to the face.

Mechanism highlighted: The review places particular emphasis on the cellular mechanism understood to underlie photobiomodulation effects. Photons at specific wavelengths are absorbed by cytochrome c oxidase, a key enzyme in the mitochondrial electron transport chain. This absorption is understood to activate ATP (adenosine triphosphate) production - the primary energy currency of cells. Increased ATP availability is theorised to support tissue repair processes including cell proliferation and protein synthesis.

Limitation to note: Narrative reviews summarise and interpret existing literature but do not themselves generate new data. The quality of a narrative review depends on the quality and breadth of the studies it draws from. It is useful for understanding the landscape of a field and identifying plausible mechanisms, but should be read alongside primary clinical research.

---

Wavelength Relevance: Where Lumovex Sits in the Research

Across the three studies reviewed above, the most commonly cited therapeutic wavelengths fall into two ranges:

• Red light: approximately 630nm-680nm - studied for surface tissue effects including fibroblast activity, collagen synthesis, and epithelial cell growth
• Near-infrared: approximately 800nm-880nm - studied for deeper tissue penetration, including musculoskeletal applications and wound healing in deeper layers

The Lumovex Spectrum Pro Mask delivers 660nm red light and 850nm near-infrared light. Both wavelengths sit within the ranges studied in the research discussed here:

• 660nm aligns with the red light range referenced in the Avci and colleagues review (630nm, 633nm, 660nm) and is close to the 670nm used in the Whelan NASA study
• 850nm falls between the 830nm referenced in Avci and colleagues and the 880nm used in the Whelan NASA study

This does not mean results from the cited studies apply directly to the Lumovex device or to any specific individual. Wavelength proximity suggests these ranges are within the studied therapeutic window, but individual outcomes vary and the research base - while growing - includes a mix of pre-clinical and clinical data.

---

Summary: Strength of Evidence

• Whelan and colleagues (2001) - Strongest primary research here. Peer-reviewed, NASA-funded, with in vitro, animal, and human case data. Limitations: human data is case-based, not a controlled trial.
• Chaves and colleagues (2014) - Useful for understanding mechanisms and confirming LED vs laser equivalence. Limitation: review of pre-clinical studies only.
• Avci and colleagues (2013) - Broad narrative review with useful mechanistic insights and clinical references. Limitation: narrative reviews vary in rigour and do not generate new data.

The overall picture from these studies is that red and near-infrared light in the therapeutic window has demonstrated biological effects relevant to wound healing across multiple pre-clinical study types, with supporting human case data. Larger randomised controlled trials in humans remain an active area of ongoing research.

For broader body coverage, the Lumovex Pro Panel 540 delivers 289 LEDs across both 660nm and 850nm wavelengths. The Lumovex Belt provides targeted treatment for the core, lower back, and surrounding joints.

---

This article is for educational and informational purposes only. It is not intended as medical advice and does not constitute a claim that any specific product will treat, cure, or prevent any condition. The studies referenced are independent academic publications and are cited for educational context only. Consult a qualified healthcare professional for any skin, wound, or health concerns.